These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32368983)

  • 1. Impact of Interleukin 28B and ICAM-1 Genetic Polymorphisms on Response to Direct Antiviral Treatment Among HCV Infected Patients.
    Elsheredy AG; Almaeen AH; Ghazy AA; Helaly GF; Amer I; Ghazy HA; Haydara T
    Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1328-1335. PubMed ID: 32368983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.
    Zakaria ZA; Knapp S; Hashem M; Zaghla H; Thursz M; Waked I; Abdelwahab S
    Immunol Res; 2019 Feb; 67(1):123-133. PubMed ID: 30402710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
    Ea R; Aa G; Ag ES; Ma A
    Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.
    Shaker O; Rashad A; Abd El Aziz G; El Raziky M
    Cell Biochem Biophys; 2015 Jan; 71(1):307-14. PubMed ID: 25115611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.
    Rizk NM; Derbala MF
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):262-8. PubMed ID: 23137758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.
    Riva E; Scagnolari C; Monteleone K; Selvaggi C; Picardi A; Mazzarelli C; Pizzigallo E; Vincenzi B; Carducci A; Antonaci S; Giannelli G; Antonelli G
    J Viral Hepat; 2012 Sep; 19(9):650-3. PubMed ID: 22863269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
    Shaker OG; Sadik NA
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children.
    Shaker OG; Nassar YH; Nour ZA; El Raziky M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):155-60. PubMed ID: 23880623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.
    Sticchi L; Di Biagio A; Rappazzo E; Setti M; De Rosa G; De Hoffer L; Nicolini L; Prinapori R; Bruzzone B
    J Prev Med Hyg; 2013 Jun; 54(2):83-6. PubMed ID: 24396987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
    Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
    Khan AJ; Saraswat VA; Ranjan P; Parmar D; Negi TS; Mohindra S
    J Med Virol; 2019 Apr; 91(4):659-667. PubMed ID: 30431653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
    Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR;
    Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.
    El-Fattah MA
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101480. PubMed ID: 32622719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.
    Palenzuela Gardón D; Guillen IA; Fernández JR; Camacho H; Estevez ZC; Dueñas S; Alvares-Lajonchere L; Amador Y; Martinez-Donato G; Han J; Zhang Z; Zhang X; Gao Y; Campaña JR; Novoa LI
    J Biomol Tech; 2017 Jul; 28(2):80-86. PubMed ID: 28058039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
    Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
    Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.
    Ito K; Higami K; Masaki N; Sugiyama M; Mukaide M; Saito H; Aoki Y; Sato Y; Imamura M; Murata K; Nomura H; Hige S; Adachi H; Hino K; Yatsuhashi H; Orito E; Kani S; Tanaka Y; Mizokami M
    J Clin Microbiol; 2011 May; 49(5):1853-60. PubMed ID: 21389156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C.
    Abdelaziz AI; Abdelsameea E; Abdel-Samiee M; Ghanem SE; Wahdan SA; Elsherbiny DA; Zakaria Z; Azab SS
    Clin Exp Med; 2024 Aug; 24(1):184. PubMed ID: 39117877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.